Mission

The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD)

Objectives

This program aims to to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). to discover and develop new and effective therapies for interstitial lung diseases, particularly idiopathic pulmonary fibrosis (IPF) and sarcoidosis, to better understand disease mechanisms through translational research, to educate physicians in training, and to reach out to the community aiming to enhance ILD awareness and help improve the standards for evaluation, treatment and follow-up of patients.

About Our Practice

Idiopathic Pulmonary Fibrosis, a disease studied in this program, is a chronic, progressive, lung disease characterized by disabling shortness of breath, declining exercise capacity and extensive formation of scar tissue (fibrosis) in the lung. There is no currently known cause or definitive treatment for idiopathic pulmonary fibrosis. This program exists to better understand such illnesses, train physicians to more completely treat such illnesses, and to drive the creation of superior treatment options.  

Pulmonary Fibrosis/Interstitial Lung Disease Program Contact Information
UAB Interstitial Lung Disease Program
THT 422, 1900 University Boulevard
Birmingham, AL 35294-0006
Phone: (205) 934-7557
Fax: (205) 934-6229

Contacting the Program for Pulmonary Fibrosis/Interstitial Lung Disease

To refer a patient to this program, please contact our office administrator at (205) 934-7557 from 8 AM-5 PM, CT, Monday-Friday.
In order to expedite the scheduling and the evaluation process, please forward the following documents to our office as soon as possible: 

1. Last clinic note or referral letter
2. Pulmonary function tests (PFTs)
3. Chest X-rays and CT scans - upload films to a CD and attach reports
4. Lung biopsy slides and reports, if available. 

After the appointment is scheduled, your patient will receive a package containing a schedule of tests and appointments, along with the "UAB ILD Program New Patient Questionnaire," maps, and information on lodging in the Kirklin Clinic area.  After the clinic visit and once all data has been reviewed, including any prior biopsies, you will receive either a letter from one of our physicians or a copy the patient's clinic visit note.